Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/6727
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Alfreda Stincarelli, Maria | - |
dc.contributor.author | Arvia, Rosaria | - |
dc.contributor.author | Giannecchini, Simone | - |
dc.date.accessioned | 2024-10-25T08:17:17Z | - |
dc.date.available | 2024-10-25T08:17:17Z | - |
dc.date.issued | 2023 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/6727 | - |
dc.description.abstract | Extracellular vesicles engagement during respiratory viruses infection Maria Alfreda Stincarelli 1, Rosaria Arvia 1, Simone Giannecchini * Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy A R T I C L E I N F O Handling Editor: Prof A Angelo Azzi Keywords: Respiratory viruses Extracellular vesicles microRNA Viral genome Viral immune evasion Interferon signaling pathways Inflammatory response Extracellular vesicles associated diseases A B S T R A C T Respiratory viruses infection is a worldwide human concern annually. The main viral respiratory diseases are caused by a variety of viruses sharing similar threats and affecting the respiratory system. Among all, influenza viruses, respiratory syncytial virus, parainfluenza viruses, respiratory adenoviruses, rhinoviruses, human bocaviruses, human metapneumovirus and coronaviruses are the main common respiratory viruses affecting human population. The recent coronavirus disease 19 pandemic has revealed critical knowledge gaps required to update in the transmission and pathological induced pathways for respiratory viruses. To date, several evidences suggest that human viruses can hijack extracellular vesicles (EVs) to deliver proteins, mRNAs, microRNAs and whole viral particles during viral life cycle in the host. Thus, several investigations have reported that also respiratory viruses use EVs to deliver viral nucleic acid and proteins, even including the potentiality of carrying whole viral particle. This evidence demonstrates the ability of the EVs produced in infected cells to deliver respiratory viral components to uninfected cells, positively or negatively counteracting new viral infection. Additionally, EVs derived from biological fluids of clinical samples may increase the risk to induce severe respiratory viruses-associated diseases in site far from the respiratory tract and for prolonged time. Here, it has been reviewed the advantages of the respiratory viruses EVs interaction regarding their ability to enhance viral infection, to evade antiviral response, to regulate virus-immune response and to mediate diseases. All these data confirm a potential role of the association between EVs and respiratory viruses infection. This suggests that further studies to define the implication of this interaction in viral life cycle in human population are needed. | en_US |
dc.subject | Respiratory viruses | en_US |
dc.subject | Extracellular vesicles microRNA | en_US |
dc.subject | Viral genome | en_US |
dc.subject | Viral immune evasion | en_US |
dc.subject | Interferon signaling pathways | en_US |
dc.subject | Inflammatory response | en_US |
dc.subject | Extracellular vesicles associated diseases | en_US |
dc.title | Extracellular vesicles engagement during respiratory viruses infection | en_US |
dc.type | Article | en_US |
Appears in Collections: | Vol 1 2023 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
100004.pdf | 816.64 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.